Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers

By F. D. De Felice, M. N. Vieira, Theresa R. Bomfim, H. Decker, P. Velasco, M. Lambert, K. Viola, Wei⁃qin Zhao, Sérgio T. Ferreira, W. Klein. Proceedings of the National Academy of Sciences of the United States of America, 2009

616 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Pharmacology, Physiology

View Paper: https://www.semanticscholar.org/paper/f83fd1ab92993abebf2d284fe60d8398949b7908

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cellular and Molecular Neuroscience

1. C. Zhong
2. Zhichun Chen

In Physiology

1. C. Zhong
2. Zhichun Chen

Citations in the corpus

• Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. (2013, background): “Some studies have proved that insulin treatment prevents the binding of Ab oligomers with IR and synapse loss (De Felice et al., 2009; Gasparini et al., 2001), as well as improves cognitive dysfunction in AD.”